Table 1 Polymorphic ratio of the investigated markers
| Â | Marker types | No. of tested markers | No. of polymorphic markers between 'Satonoka' and 'Kintoki' | % | No. of polymorphic markers between 'Nakateyutaka' and 'YI-0311' | % | References |
|---|---|---|---|---|---|---|---|
DNA markers developed in this study | Â | Â | Â | Â | |||
| Â | Genomic SSRs | 2167 | 624 | 28.8 | 189 | 8.7 | This study |
| Â | Transposons | 535 | 302 | 56.4 | 67 | 12.5 | This study |
DNA markers derived from other studies | Â | Â | Â | Â | |||
| Â | Genomic SSRs | 418 | 87 | 20.8 | 18 | 4.3 | |
| Â | EST-SSRs | 3375 | 50 | 1.5 | 9 | 0.3 | |
| Â | BAC-end SSRs | 152 | 25 | 16.4 | 6 | 3.9 | Bertioli, pers. comm. |
| Â | Transposons | 504 | 91 | 18.1 | 49 | 9.7 | [34] |
Total | Â | 7151 | 1179 | 16.5 | 338 | 4.7 | Â |